The Peptide Therapeutics Market is expected to exceed more than US$ 45 bn by 2024. The market is predicted to register a promising 9% CAGR between 2018 and 2024. Surging importance peptide therapeutics in the treatment of several diseases including cancer, nervous system disorders, ovarian cancer, breast cancer, and gastrointestinal cancers are fuelling product landscape. Increasing R&D investment by the major companies for improving efficacy owing to the absence of toxicity in the product portfolio. It is leading towards the development of excellent peptide therapeutic drugs is projected to boost industry growth.
Browse Full Report: https://www.marketresearchengine.com/peptide-therapeutics-market
Global peptide therapeutics market is segregated on the basis of applications as cancer, metabolic, CVD, respiratory, GIT, anti-infective, dermatology, CNS, and renal. Cancer is expected to witness notable gains in the forecast years. The report segments global peptide therapeutics market based on technology as liquid phase, solid phase, and hybrid phase.
Global peptide therapeutics market share consists of several players including Eli Lilly and Company, Merck & Co, CordenPharma International, AstraZeneca Plc, Ipsen S.A, PolyPeptide Group, Teva Pharmaceutical, Bachem AG, and Novo Nordisk A/S.
Rising adoption of cost-effective measures by the physicians is accompanied by the risen healthcare expenditures from the several government authorities propelling product demand. Peptide consists of short amino acid monomer chains. However, production in large scale due to complexities peptide has become a major challenge for the biotech and pharmaceutical companies. New product developments such as multifunctional peptides through the hybrid technology are anticipated to drive market size.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The global peptide therapeutics market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
Global peptide therapeutics market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional peptide therapeutics market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Company 1, Company 2, …Company N.
The report covers:
- Global peptide therapeutics market estimates & forecast from 2015 to 2024, with CAGR for 2018-2024.
- Comparative market size analysis for 2017 & 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
- Global peptide therapeutics market trends, with detailed analysis on consumer trends & manufacturer trends
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors
- Key areas of investments identifying market opportunities and challenges in forecast timeframe
- Competitive analysis of the industry players along with the overview on strategic management
- Comprehensive company profiles of the major industry players
Reasons to Buy this Report:
- Gain comprehensive insights on the industry trends
- Identify industry opportunities and key growth segments
- Obtain complete market study on the peptide therapeutics market
- Facilitate strategy planning for your company based on the industry dynamics
- Evaluate your competitor’s business segments and portfolios
The Peptide Therapeutics Market has been segmented as below:
The Peptide Therapeutics Marketis segmented on the lines ofPeptide Therapeutics Market, By Application, Peptide Therapeutics Market, By Route of Administration, Peptide Therapeutics Market, By Type, Peptide Therapeutics Market, By Technology, Peptide Therapeutics Market, By Type of Molecule, Peptide Therapeutics Market, By API Peptide Type and Peptide Therapeutics Market, By Region.
Peptide Therapeutics Market, By Applicationthis market is segmented on the basis ofCancer, Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS and Renal. Peptide Therapeutics Market, By Route of Administrationthis market is segmented on the basis ofParenteral and Oral. Peptide Therapeutics Market, By Type this market is segmented on the basis ofInnovative and Generic. Peptide Therapeutics Market, By Technologythis market is segmented on the basis ofLiquid Phase, Solid Phase and Hybrid Phase. Peptide Therapeutics Market, By Type of Molecule this market is segmented on the basis ofVasopressin, Somatostatin, Calcitonin, Natriuretic and Immunopeptide. Peptide Therapeutics Market, By API Peptide Type this market is segmented on the basis ofIn-house and CMO. Peptide Therapeutics Market, By Regionthis market is segmented on the basis ofNorth America, Europe, Asia Pacific and Rest of World.
Request Sample Report from here: https://www.marketresearchengine.com/peptide-therapeutics-market
Table of Contents:
- Research Methodology
- Executive Summary
- Market Overview
4.2.1. Driver 1
4.2.2. Driver 2
4.2.3. Driver 3
4.3.1. Restraint 1
4.3.2. Restraint 2
4.4.1. Opportunity 1
4.4.2. Opportunity 2
4.5.1. Challenge 1
4.5.2. Challenge 2
- Peptide Therapeutics Market, By Application
- Peptide Therapeutics Market, By Route of Administration
- Peptide Therapeutics Market, By Type
- Peptide Therapeutics Market, By Technology
- Peptide Therapeutics Market, By Type of Molecule
- Peptide Therapeutics Market,By API Peptide Type
- Competitive Landscape
- Company Profile
12.1. Eli Lilly and Company
12.1.1. Company Overview
12.1.2. Product/Service Landscape
12.1.3. Financial Overview
12.1.4. Recent Developments
12.2. Merck & Co
12.2.1. Company Overview
12.2.2. Product/Service Landscape
12.2.3. Financial Overview
12.2.4. Recent Developments
12.3. CordenPharma International
12.3.1. Company Overview
12.3.2. Product/Service Landscape
12.3.3. Financial Overview
12.3.4. Recent Developments
12.4. AstraZeneca Plc
12.4.1. Company Overview
12.4.2. Product/Service Landscape
12.4.3. Financial Overview
12.4.4. Recent Developments
12.5. Ipsen S.A
12.5.1. Company Overview
12.5.2. Product/Service Landscape
12.5.3. Financial Overview
12.5.4. Recent Developments
12.6. PolyPeptide Group
12.6.1. Company Overview
12.6.2. Product/Service Landscape
12.6.3. Financial Overview
12.6.4. Recent Developments
12.7. Teva Pharmaceutical
12.7.1. Company Overview
12.7.2. Product/Service Landscape
12.7.3. Financial Overview
12.7.4. Recent Developments
12.8. Bachem AG
12.8.1. Company Overview
12.8.2. Product/Service Landscape
12.8.3. Financial Overview
12.8.4. Recent Developments
12.9. Novo Nordisk A/S.
12.9.1. Company Overview
12.9.2. Product/Service Landscape
12.9.3. Financial Overview
12.9.4. Recent Developments
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Company Name: Market Research Engine
Contact Person: John Bay
Email: [email protected]
Country: United States